RATIONALE: Epidemiological studies have suggested a beneficial effect of fish oil supplementation in halting the initial progression of Alzheimer's disease. However, it remains unclear whether fish oil affects cognitive function in older people with mild cognitive impairment (MCI). OBJECTIVES: This study investigated the effects of fish oil supplementation on cognitive function in elderly person with MCI. METHODS: This was a 12-month, randomised, double-blind, placebo-controlled study using fish oil supplementation with concentrated docosahexaenoic acid (DHA). Thirty six low-socioeconomic-status elderly subjects with MCI were randomly assigned to receive either concentrated DHA fish oil (n = 18) or placebo (n = 18) capsules. The changes of memory, psychomotor speed, executive function and attention, and visual-constructive skills were assessed using cognitive tests. Secondary outcomes were safety and tolerability of the DHA concentrate. RESULTS: The fish oil group showed significant improvement in short-term and working memory (F = 9.890; ηp (2) = 0.254; p < 0.0001), immediate verbal memory (F = 3.715; ηp (2) = 0.114; p < 0.05) and delayed recall capability (F = 3.986; ηp (2) = 0.121; p < 0.05). The 12-month change in memory (p < 0.01) was significantly better in the fish oil group. Fish oil consumption was well tolerated, and the side effects were minimal and self-limiting. CONCLUSIONS: This study suggested the potential role of fish oil to improve memory function in MCI subjects. Studies with larger sample sizes, longer intervention periods, different fish oil dosages and genetic determinations should be investigated before definite recommendations can be made.
RCT Entities:
RATIONALE: Epidemiological studies have suggested a beneficial effect of fish oil supplementation in halting the initial progression of Alzheimer's disease. However, it remains unclear whether fish oil affects cognitive function in older people with mild cognitive impairment (MCI). OBJECTIVES: This study investigated the effects of fish oil supplementation on cognitive function in elderly person with MCI. METHODS: This was a 12-month, randomised, double-blind, placebo-controlled study using fish oil supplementation with concentrated docosahexaenoic acid (DHA). Thirty six low-socioeconomic-status elderly subjects with MCI were randomly assigned to receive either concentrated DHA fish oil (n = 18) or placebo (n = 18) capsules. The changes of memory, psychomotor speed, executive function and attention, and visual-constructive skills were assessed using cognitive tests. Secondary outcomes were safety and tolerability of the DHA concentrate. RESULTS: The fish oil group showed significant improvement in short-term and working memory (F = 9.890; ηp (2) = 0.254; p < 0.0001), immediate verbal memory (F = 3.715; ηp (2) = 0.114; p < 0.05) and delayed recall capability (F = 3.986; ηp (2) = 0.121; p < 0.05). The 12-month change in memory (p < 0.01) was significantly better in the fish oil group. Fish oil consumption was well tolerated, and the side effects were minimal and self-limiting. CONCLUSIONS: This study suggested the potential role of fish oil to improve memory function in MCI subjects. Studies with larger sample sizes, longer intervention periods, different fish oil dosages and genetic determinations should be investigated before definite recommendations can be made.
Authors: Lai Kuan Lee; Suzana Shahar; NorFadilah Rajab; Noor Aini Mohd Yusoff; Rahman A Jamal; Sue Mian Then Journal: J Nutr Biochem Date: 2012-08-13 Impact factor: 6.048
Authors: Alan D Dangour; Elizabeth Allen; Diana Elbourne; Nicky Fasey; Astrid E Fletcher; Pollyanna Hardy; Graham E Holder; Rosemary Knight; Louise Letley; Marcus Richards; Ricardo Uauy Journal: Am J Clin Nutr Date: 2010-04-21 Impact factor: 7.045
Authors: P Barberger-Gateau; C Raffaitin; L Letenneur; C Berr; C Tzourio; J F Dartigues; A Alpérovitch Journal: Neurology Date: 2007-11-13 Impact factor: 9.910
Authors: Paul F Boston; Amanda Bennett; David F Horrobin; Crispin N Bennett Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2004-11 Impact factor: 4.006
Authors: T Sunderland; J L Hill; A M Mellow; B A Lawlor; J Gundersheimer; P A Newhouse; J H Grafman Journal: J Am Geriatr Soc Date: 1989-08 Impact factor: 5.562
Authors: Andrew Scholey; Anastasia Ossoukhova; Lauren Owen; Alvin Ibarra; Andrew Pipingas; Kan He; Marc Roller; Con Stough Journal: Psychopharmacology (Berl) Date: 2010-07-31 Impact factor: 4.530
Authors: Andrea M McGrattan; Claire T McEvoy; Bernadette McGuinness; Michelle C McKinley; Jayne V Woodside Journal: Br J Nutr Date: 2018-11-09 Impact factor: 3.718
Authors: Lori A Daiello; Assawin Gongvatana; Shira Dunsiger; Ronald A Cohen; Brian R Ott Journal: Alzheimers Dement Date: 2014-06-18 Impact factor: 21.566
Authors: Lisa M Jaremka; Heather M Derry; Robert Bornstein; Ruchika Shaurya Prakash; Juan Peng; Martha A Belury; Rebecca R Andridge; William B Malarkey; Janice K Kiecolt-Glaser Journal: Psychosom Med Date: 2014-10 Impact factor: 4.312
Authors: J P Schuchardt; T Köbe; V Witte; J Willers; A Gingrich; V Tesky; J Pantel; D Rujescu; T Illig; A Flöel; A Hahn Journal: J Nutr Health Aging Date: 2016 Impact factor: 4.075
Authors: Edmond Teng; Karen Taylor; Tina Bilousova; David Weiland; Thaidan Pham; Xiaohong Zuo; Fusheng Yang; Ping-Ping Chen; Charles G Glabe; Alison Takacs; Dennis R Hoffman; Sally A Frautschy; Gregory M Cole Journal: Neurobiol Dis Date: 2015-09-12 Impact factor: 5.996